XBI Stock Summary and Trading Ideas (State Street SPDR S&P Biotech ETF | ARCA:XBI)

State Street SPDR S&P Biotech ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "Index"), the Fund employs a sampling strategy, which means that the Fund is not required to purchase all of the securities represented in the Index. The Index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI"). The S&P TMI is designed to track the broad U.S. equity market. The biotechnology segment of the S&P TMI comprises the Biotechnology sub-industry. The Index is one of twenty-one (21) of the S&P Select Industry Indices (the "Select Industry Indices"), each designed to measure the performance of a narrow sub-industry or group of sub-industries determined based on the Global Industry Classification Standard ("GICS"). Membership in the Select Industry Indices is based on the GICS classification, as well as liquidity and market cap requirements.

What symbol and exchange does State Street SPDR S&P Biotech ETF shares trade?

State Street SPDR S&P Biotech ETF trades on the ARCA stock market under the symbol XBI.

What is State Street SPDR S&P Biotech ETF stock price doing today?

As of July 8, 2026, XBI stock price declined to $162.97 with 10,271,450 million shares trading.

What is State Street SPDR S&P Biotech ETF's Beta?

XBI has a beta of 0.81, meaning it tends to be less sensitive to market movements. XBI has a correlation of 0.17 to the broad based SPY ETF.

How much is State Street SPDR S&P Biotech ETF worth?

XBI has a market cap of $11.02 billion. This is considered a Large Cap stock.

What is the highest and lowest price State Street SPDR S&P Biotech ETF traded in the last 3 year period?

In the last 3 years, XBI traded as high as $164.35 and as low as $63.80.

Is State Street SPDR S&P Biotech ETF (XBI) a good investment?

XBI has outperformed the market in the last year with a price return of +95.7% while the SPY ETF gained +21.3%. XBI has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +26.6% and +10.8%, respectively, while the SPY returned +13.4% and +1.6%, respectively.

What are the support and resistance levels for State Street SPDR S&P Biotech ETF (XBI)?

XBI support price is $160.76 and resistance is $166.98 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that XBI shares will trade within this expected range on the day.